131 related articles for article (PubMed ID: 23927996)
21. Current imaging modalities to visualize vulnerability within the atherosclerotic carotid plaque.
Wallis de Vries BM; van Dam GM; Tio RA; Hillebrands JL; Slart RH; Zeebregts CJ
J Vasc Surg; 2008 Dec; 48(6):1620-9. PubMed ID: 18804942
[TBL] [Abstract][Full Text] [Related]
22. Clinical imaging in anti-atherosclerosis drug development.
Ehlgen A; Bylock A; Kreuzer J; Koslowski M; Gantner F; Niessen HG
Drug Discov Today; 2015 Nov; 20(11):1317-27. PubMed ID: 26151479
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging.
Bala G; Cosyns B
Curr Cardiol Rep; 2014 Sep; 16(9):520. PubMed ID: 25059464
[TBL] [Abstract][Full Text] [Related]
24. Molecular imaging of atherosclerosis with integrated PET imaging.
Hammad B; Evans NR; Rudd JHF; Tawakol A
J Nucl Cardiol; 2017 Jun; 24(3):938-943. PubMed ID: 28078575
[TBL] [Abstract][Full Text] [Related]
25. Roles of nuclear cardiology, cardiac computed tomography, and cardiac magnetic resonance: Noninvasive risk stratification and a conceptual framework for the selection of noninvasive imaging tests in patients with known or suspected coronary artery disease.
Berman DS; Hachamovitch R; Shaw LJ; Friedman JD; Hayes SW; Thomson LE; Fieno DS; Germano G; Wong ND; Kang X; Rozanski A
J Nucl Med; 2006 Jul; 47(7):1107-18. PubMed ID: 16818945
[TBL] [Abstract][Full Text] [Related]
26. Accurate magnetic resonance imaging of atherosclerotic plaques: change future strategies for the diagnosis and therapy of atherosclerotic disease.
Liu XS; Xu JR
Med Hypotheses; 2007; 68(3):656-60. PubMed ID: 17014968
[TBL] [Abstract][Full Text] [Related]
27. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
Corti R
Pharmacol Ther; 2006 Apr; 110(1):57-70. PubMed ID: 16445985
[TBL] [Abstract][Full Text] [Related]
28. Molecular imaging of atherosclerosis: clinical state-of-the-art.
Jaffer FA; Verjans JW
Heart; 2014 Sep; 100(18):1469-77. PubMed ID: 24365664
[TBL] [Abstract][Full Text] [Related]
29. Evaluating efficacy of pharmaceutical interventions in atherosclerosis: role of magnetic resonance imaging and positron emission tomography.
Hyafil F; Feldman L; Le Guludec D; Fayad ZA
Mt Sinai J Med; 2012; 79(6):689-704. PubMed ID: 23239208
[TBL] [Abstract][Full Text] [Related]
30. Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol.
Kühl HP; Lipke CS; Krombach GA; Katoh M; Battenberg TF; Nowak B; Heussen N; Buecker A; Schaefer WM
Eur Heart J; 2006 Apr; 27(7):846-53. PubMed ID: 16434414
[TBL] [Abstract][Full Text] [Related]
31. Regions of low endothelial shear stress colocalize with positive vascular remodeling and atherosclerotic plaque disruption: an in vivo magnetic resonance imaging study.
Phinikaridou A; Hua N; Pham T; Hamilton JA
Circ Cardiovasc Imaging; 2013 Mar; 6(2):302-10. PubMed ID: 23357244
[TBL] [Abstract][Full Text] [Related]
32. Imaging of oxidation-specific epitopes with targeted nanoparticles to detect high-risk atherosclerotic lesions: progress and future directions.
Briley-Saebo K; Yeang C; Witztum JL; Tsimikas S
J Cardiovasc Transl Res; 2014 Nov; 7(8):719-36. PubMed ID: 25297940
[TBL] [Abstract][Full Text] [Related]
33. PET, CT and MRI characterisation of the atherosclerotic plaque.
Lucignani G; Schäfers M
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2398-402. PubMed ID: 20878402
[No Abstract] [Full Text] [Related]
34. Targeted Molecular Imaging of Cardiovascular Diseases by Iron Oxide Nanoparticles.
Vazquez-Prada KX; Lam J; Kamato D; Xu ZP; Little PJ; Ta HT
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):601-613. PubMed ID: 33356385
[TBL] [Abstract][Full Text] [Related]
35. Imaging inflammation and neovascularization in atherosclerosis: clinical and translational molecular and structural imaging targets.
Osborn EA; Jaffer FA
Curr Opin Cardiol; 2015 Nov; 30(6):671-80. PubMed ID: 26398413
[TBL] [Abstract][Full Text] [Related]
36. Whole-Body Atherosclerosis Imaging by Positron Emission Tomography/Magnetic Resonance Imaging: From Mice to Nonhuman Primates.
Calcagno C; Pérez-Medina C; Mulder WJM; Fayad ZA
Arterioscler Thromb Vasc Biol; 2020 May; 40(5):1123-1134. PubMed ID: 32237905
[TBL] [Abstract][Full Text] [Related]
37. Molecular imaging of atherosclerosis for improving diagnostic and therapeutic development.
Quillard T; Libby P
Circ Res; 2012 Jul; 111(2):231-44. PubMed ID: 22773426
[TBL] [Abstract][Full Text] [Related]
38. Small animal positron emission tomography imaging and in vivo studies of atherosclerosis.
Hag AM; Ripa RS; Pedersen SF; Bodholdt RP; Kjaer A
Clin Physiol Funct Imaging; 2013 May; 33(3):173-85. PubMed ID: 23522010
[TBL] [Abstract][Full Text] [Related]
39. Positron emission tomography imaging of atherosclerosis.
Orbay H; Hong H; Zhang Y; Cai W
Theranostics; 2013 Nov; 3(11):894-902. PubMed ID: 24312158
[TBL] [Abstract][Full Text] [Related]
40. Translating Molecular Imaging of the Vulnerable Plaque-a Vulnerable Project?
Bala G; Broisat A; Lahoutte T; Hernot S
Mol Imaging Biol; 2018 Jun; 20(3):337-339. PubMed ID: 29181819
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
